MercadoLibre, Inc. Reports Second Quarter 2020 Financial Results
Net Revenues of $878.4 million, up 123.4% year-over-year on an FX neutral basis$11.2 billion Total Payment Volume, up 142.1% year-over-year […]
Professional Diversity Network, Inc. Subsidiary IAW Announces Launch of Virtual Networking Platform
CHICAGO, Aug. 10, 2020 (GLOBE NEWSWIRE) — International Association of Women (“IAW”) today announced the launch of extended virtual programs. […]
SCYNEXIS Reports Second Quarter 2020 Financial Results and Provides Company Update
In July, SCYNEXIS announced that it had successfully conducted pre-NDA meetings with the FDA regarding ibrexafungerp for the treatment of […]
Sean Murphy joins Radius Health Board of Directors
WALTHAM, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) — Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced the […]
Radius Health Announces Second Quarter 2020 Operating Results
TYMLOS® U.S. net sales of $50 million, with 22% year over year growthCompletion of enrollment in ATOM Phase 3 expected […]
Adaptive Biotechnologies to Present at the UBS Genomics 2.0 and Medtech Innovations Summit
SEATTLE, Aug. 10, 2020 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate […]
Guardant Health to Participate in Upcoming August Investor Conferences
REDWOOD CITY, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) today announced the company will be […]
AnaptysBio Announces Second Quarter 2020 Financial Results and Provides Pipeline Updates
Interim 8-Week Top-Line Data From Etokimab ECLIPSE Phase 2 Trial in Chronic Rhinosinusitis with Nasal Polyps Did Not Demonstrate Statistical […]
Cellectar Reports Second Quarter 2020 Financial Results and Provides a Corporate Update
FLORHAM PARK, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the […]
TORM plc to announce second quarter and first half 2020 results
TORM plc (“TORM” or the “Company”) (ticker: TRMD A on Nasdaq in Copenhagen and TRMD on Nasdaq in New York) […]
